Compare Intercept Pharmaceuticals vs KeyNeurotek Pharmaceuticals
Customers evaluate the quality of Intercept Pharmaceuticals's products using the following success metrics.
Overview
Intercept Pharmaceuticals is 22 yrs old and is based in United States.
Intercept is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe, and Canada.
KeyNeurotek Pharmaceuticals is based in Germany
KeyNeurotek Pharmaceuticals is a clinical stage small molecule company focused on autoimmune and CNS diseases.
Demo Video
Leadership
Mark Pruzanski (Founder)
Frank Striggow (Chief Executive Officer)
Funding
Investors
Genextra, OrbiMed Advisors
IBG Beteiligungsgesellschaft, Deutsche Venture Capital
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Intercept Pharmaceuticals has not claimed their profile.
Work for Intercept Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Intercept Pharmaceuticals?
Claim your profile now.
Information not available because KeyNeurotek Pharmaceuticals has not claimed their profile.
Work for KeyNeurotek Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for KeyNeurotek Pharmaceuticals?
Claim your profile now.